Invention Grant
- Patent Title: T-cell modulatory multimeric polypeptides and methods of use thereof
-
Application No.: US17578094Application Date: 2022-01-18
-
Publication No.: US11377478B2Publication Date: 2022-07-05
- Inventor: Ronald D. Seidel, III , Rodolfo J. Chaparro
- Applicant: Cue Biopharma, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Cue Biopharma, Inc.
- Current Assignee: Cue Biopharma, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Bozicevic Field & Francis, LLP
- Agent Paula A. Borden
- Main IPC: C07K14/55
- IPC: C07K14/55 ; A61K35/17 ; C07K14/47 ; C07K14/74 ; A61K9/00 ; C07K14/005 ; G01N33/50 ; A61K38/00 ; A61K39/00

Abstract:
The present disclosure provides variant immunomodulatory polypeptides, and fusion polypeptides comprising the variant immunomodulatory peptides. The present disclosure provides T-cell modulatory multimeric polypeptides, and compositions comprising same, where the T-cell modulatory multimeric polypeptides comprise a variant immunomodulatory polypeptide of the present disclosure. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the T-cell modulatory multimeric polypeptides, and host cells comprising the nucleic acids. The present disclosure provides methods of modulating the activity of a T cell; the methods comprise contacting the T cell with a T-cell modulatory multimeric polypeptide of the present disclosure.
Public/Granted literature
- US20220177536A1 T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF Public/Granted day:2022-06-09
Information query